Surgical intervention after neoadjuvant therapy in esophageal cancer: a narrative review

CONCLUSIONS: Neoadjuvant therapy combined with surgery is the gold standard for resectable esophageal cancer. However, optimal timing of surgery after preoperative treatment remains unclear. Minimally invasive thoracoscopic surgery (including robotic surgery) has gradually replaced traditional open surgery. Active prevention before operation, accurate and meticulous operation during operation, and timely treatment after operation can minimize the incidence of adverse events.PMID:37197518 | PMC:PMC10183507 | DOI:10.21037/jtd-23-420
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Authors: Source Type: research